HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Figures Only Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Schindler, T. H. Articles by Schelbert, H. R. Search for Related Content PubMed PubMed Citation Articles by Schindler, T. H. Articles by Schelbert, H. R.

PET-Measured Responses of MBF to Cold Pressor Testing Correlate with Indices of Coronary Vasomotion on Quantitative Coronary Angiography

¹ Department of Molecular and Medical Pharmacology, David Geffen School of Medicine at UCLA, University of California, Los Angeles, California
² Division of Cardiology and Nuclear Medicine, Medical Clinic III, University Hospital of Albert Ludwigs University, Freiburg, Germany
³ Department of Medical Statistics and Biometry, Albert Ludwigs University, Freiburg, Germany

The aims of this study were to determine whether responses in myocardial blood flow (MBF) to the cold pressor testing (CPT) method noninvasively with PET correlate with an established and validated index of flow-dependent coronary vasomotion on quantitative angiography. Methods: Fifty-six patients (57 ± 6 y; 16 with hypertension, 10 with hypercholesterolemia, 8 smokers, and 22 without coronary risk factors) with normal coronary angiograms were studied. Biplanar end-diastolic images of a selected proximal segment of the left anterior descending artery (LAD) (n = 27) or left circumflex artery (LCx) (n = 29) were evaluated with quantitative coronary angiography in order to determine the CPT-induced changes of epicardial luminal area (LA, mm²). Within 20 d of coronary angiography, MBF in the LAD, LCx, and right coronary artery territory was measured with ¹³N-ammonia and PET at baseline and during CPT. Results: CPT induced on both study days comparable percent changes in the rate x pressure product (%RPP, 37% ± 13% and 40% ± 17%; P = not significant [NS]). For the entire study group, the epicardial LA decreased from 5.07 ± 1.02 to 4.88 ± 1.04 mm² (LA, -0.20 ± 0.89 mm²) or by -2.19% ± 17%, while MBF in the corresponding epicardial vessel segment increased from 0.76 ± 0.16 to 1.03 ± 0.33 mL · min^-1 · g^-1 (MBF, 0.27 ± 0.25 mL · min^-1 · g^-1) or 36% ± 31% (P 0.0001). However, in normal controls without coronary risk factors (n = 22), the epicardial LA increased from 5.01 ± 1.07 to 5.88 ± 0.89 mm² (19.06% ± 8.9%) and MBF increased from 0.77 ± 0.16 to 1.34 ± 0.34 mL · min^-1 · g^-1 (74.08% ± 23.5%) during CPT, whereas patients with coronary risk factors (n = 34) revealed a decrease of epicardial LA from 5.13 ± 1.48 to 4.24 ± 1.12 mm² (-15.94% ± 12.2%) and a diminished MBF increase (from 0.76 ± 0.20 to 0.83 ± 0.25 mL · min^-1 · g^-1 or 10.91% ± 19.8%) as compared with controls (P < 0.0001, respectively), despite comparable changes in the RPP (P = NS). In addition, there was a significant correlation (r = 0.87; P 0.0001) between CPT-related percent changes in LA on quantitative angiography and in MBF as measured with PET. Conclusion: The observed close correlation between an angiographically established parameter of flow-dependent and, most likely, endothelium-mediated coronary vasomotion and PET-measured MBF further supports the validity and value of MBF responses to CPT as a noninvasively available index of coronary circulatory function.

Key Words: blood flow • cold pressor test • endothelium, PET • vasoconstriction

This article has been cited by other articles:

				H. R. Schelbert Coronary circulatory function abnormalities in insulin resistance insights from positron emission tomography. J. Am. Coll. Cardiol., February 3, 2009; 53(5 Suppl): S3 - S8. [Abstract] [Full Text] [PDF]

				T H Schindler, A D Facta, J O Prior, J Cadenas, W A Hsueh, M J Quinones, and H R Schelbert Improvement in coronary vascular dysfunction produced with euglycaemic control in patients with type 2 diabetes Heart, March 1, 2007; 93(3): 345 - 349. [Abstract] [Full Text] [PDF]

				K. Morita, T. Tsukamoto, M. Naya, K. Noriyasu, M. Inubushi, T. Shiga, C. Katoh, Y. Kuge, H. Tsutsui, and N. Tamaki Smoking Cessation Normalizes Coronary Endothelial Vasomotor Response Assessed with 15O-Water and PET in Healthy Young Smokers J. Nucl. Med., December 1, 2006; 47(12): 1914 - 1920. [Abstract] [Full Text] [PDF]

				P. T. Siegrist, O. Gaemperli, P. Koepfli, T. Schepis, M. Namdar, I. Valenta, F. Aiello, S. Fleischmann, H. Alkadhi, and P. A. Kaufmann Repeatability of Cold Pressor Test-Induced Flow Increase Assessed with H215O and PET J. Nucl. Med., September 1, 2006; 47(9): 1420 - 1426. [Abstract] [Full Text] [PDF]

				T. H. Schindler, J. Cardenas, J. O. Prior, A. D. Facta, M. C. Kreissl, X.-L. Zhang, J. Sayre, M. Dahlbom, J. Licinio, and H. R. Schelbert Relationship Between Increasing Body Weight, Insulin Resistance, Inflammation, Adipocytokine Leptin, and Coronary Circulatory Function J. Am. Coll. Cardiol., March 21, 2006; 47(6): 1188 - 1195. [Abstract] [Full Text] [PDF]

				J. O. Prior, M. J. Quinones, M. Hernandez-Pampaloni, A. D. Facta, T. H. Schindler, J. W. Sayre, W. A. Hsueh, and H. R. Schelbert Coronary Circulatory Dysfunction in Insulin Resistance, Impaired Glucose Tolerance, and Type 2 Diabetes Mellitus Circulation, May 10, 2005; 111(18): 2291 - 2298. [Abstract] [Full Text] [PDF]

				T. H. Schindler, E. U. Nitzsche, H. R. Schelbert, M. Olschewski, J. Sayre, M. Mix, I. Brink, X.-L. Zhang, M. Kreissl, N. Magosaki, et al. Positron Emission Tomography-Measured Abnormal Responses of Myocardial Blood Flow to Sympathetic Stimulation Are Associated With the Risk of Developing Cardiovascular Events J. Am. Coll. Cardiol., May 3, 2005; 45(9): 1505 - 1512. [Abstract] [Full Text] [PDF]